US Patent 10781242 Interleukin-2 fusion proteins and uses thereof
Patent 10781242 was granted and assigned to Medicenna Therapeutics Corp. on September, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
107812420
Date of Patent
September 22, 2020
0Patent Application Number
150247920
Date Filed
September 24, 2014
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10781242 Interleukin-2 fusion proteins and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10781242
Date of patent
September 22, 2020
Patent application number
15024792
Date Filed
September 24, 2014
Patent primary examiner
Find more entities like US Patent 10781242 Interleukin-2 fusion proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
